Now livetag icon
What will define the 2026 holiday season? 🔎 See how shoppers are deciding. Download the report →banner icon

Nerivio app analytics for April 3

Nerivio

Nerivio

  • Theranica Ltd.
  • Apple App Store
  • Free
  • Medical
Control your Nerivio device and track your migraine headaches. The Nerivio app controls the Nerivio device - a wireless remote electrical neuromodulation device for the acute and/or preventive treatment of migraine with or without aura in patients 12 years of age or older. This prescribed device is self-applied to the upper-arm and should be used in the home environment at the onset of migraine headache or aura, or every other day for preventive treatment. Track your headaches and migraine symptoms in an easy-to-use advanced migraine diary which is included in the app. To provide you with optimal user experience for managing your migraine, the app may require access to HealthKit for sleep information. For detailed information on the Nerivio device, please refer to https://nerivio.com/ Nerivio(R) is a prescription device. Use the Nerivio device and this app only if you have a valid prescription and after consulting with your health care professional.
Nerivio

Store Rank

The Store Rank is based on multiple parameters set by Google and Apple.

All Categories in
United States--
Medical in
United States--
Create an account to see avg.monthly downloadsContact us

Nerivio Ranking Stats Over Time

Similarweb's Usage Rank & Apple App Store Rank for Nerivio

Rank

No Data Available

Nerivio Ranking by Country

Counties in which Nerivio has the highest ranking in its main categories

No Data to Display

Top Competitors & Alternative Apps

Apps with a high probability of being used by the same users, from the same store.

NeuroSphere Digital Health App

NeuroSphere Digital Health App

Abbott

Urinify

Urinify

ONMSOFT Inc.

MyLATITUDE

MyLATITUDE

Boston Scientific

EczemaWise: Eczema Skin Care

EczemaWise: Eczema Skin Care

National Eczema Association for Science and Education Inc

Nerivio VS.

April 3, 2026